Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Mon, 06.10.2025
Swissnet AG (formerly Beaconsmind AG)
Company Name:
Swissnet AG (formerly Beaconsmind AG)
ISIN:
CH0451123589
Reason for the research:
Last rating change:
Analyst:
Christian Orquera
First Berlin Equity Research has published a research update on swissnet AG (ISIN: CH0451123589). Analyst Christian Orquera reiterated his BUY rating and maintained his EUR 19.00 price ta [ … ]
Wed, 01.10.2025
Marinomed Biotech AG
Company Name:
Marinomed Biotech AG
ISIN:
ATMARINOMED6
Reason for the research:
Update
Recommendation:
Buy
from:
01.10.2025
Target price:
50,00 Euro
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Alexander Rihane
First Berlin Equity Research hat ein Research Update zu Marinomed Biotech AG (ISIN: ATMARINOMED6 [ … ]
Tue, 30.09.2025
Schloss Wachenheim AG
Company Name:
Schloss Wachenheim AG
ISIN:
DE0007229007
Reason for the research:
2024/25 Annual report
Recommendation:
Buy
from:
30.09.2025
Target price:
€19
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Simon Scholes
First Berlin Equity Research has published a research update on Schloss Wachenheim AG [ … ]
Mon, 29.09.2025
Knaus Tabbert AG
Company Name:
Knaus Tabbert AG
ISIN:
DE000A2YN504
Reason for the research:
Gewinnwarnung
Recommendation:
Kaufen
from:
29.09.2025
Target price:
€24
Target price on sight of:
12 Monate
Last rating change:
-
Analyst:
Ellis Acklin
First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG (ISIN: DE000A2YN504) ve [ … ]
Fri, 26.09.2025
Jaguar Health Inc
Company Name:
Jaguar Health Inc
ISIN:
US47010C8055
Reason for the research:
Update
Recommendation:
BUY
from:
26.09.2025
Target price:
USD 35
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Christian Orquera
First Berlin Equity Research has published a research update on Jaguar Health, Inc. (ISIN: US47010C805 [ … ]
Mon, 22.09.2025
Verve Group SE
Company Name:
Verve Group SE
ISIN:
SE0018538068
Reason for the research:
M&A
Recommendation:
Kaufen
from:
22.09.2025
Target price:
€5,10
Target price on sight of:
12 Monate
Last rating change:
-
Analyst:
Ellis Acklin
First Berlin Equity Research hat ein Research Update zu Verve Group SE (ISIN: SE0018538068) veröf [ … ]
Thu, 18.09.2025
MPH Health Care AG
Company Name:
MPH Health Care AG
ISIN:
DE000A289V03
Reason for the research:
Sechsmonatsbericht
Recommendation:
Kaufen
from:
18.09.2025
Target price:
€37
Target price on sight of:
12 Monate
Last rating change:
-
Analyst:
Ellis Acklin
First Berlin Equity Research hat ein Research Update zu MPH Health Care AG (ISIN: DE000A2 [ … ]
Wed, 17.09.2025
Formycon AG
Company Name:
Formycon AG
ISIN:
DE000A1EWVY8
Reason for the research:
Update
Recommendation:
Buy
from:
17.09.2025
Target price:
€48
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Simon Scholes
First Berlin Equity Research has published a research update on Formycon AG (ISIN: DE000A1EWVY8). Analyst Simo [ … ]
Tue, 16.09.2025
LAIQON AG
Company Name:
LAIQON AG
ISIN:
DE000A12UP29
Reason for the research:
Update
Recommendation:
BUY
from:
16.09.2025
Target price:
EUR 10.50
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Christian Orquera
First Berlin Equity Research has published a correction of the research update on LAIQON AG (ISIN: DE000A12 [ … ]
Tue, 16.09.2025
LAIQON AG
Company Name:
LAIQON AG
ISIN:
DE000A12UP29
Reason for the research:
Update
Recommendation:
BUY
from:
16.09.2025
Target price:
EUR 10.50
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Christian Orquera
First Berlin Equity Research has published a research update on LAIQON AG (ISIN: DE000A12UP29). Analyst Chr [ … ]
